Maya Haus‐Cohen

Functional Comparison of Engineered T Cells Carrying a Native TCR versus TCR-like Antibody–Based Chimeric Antigen Receptors Indicates Affinity/Avidity Thresholds

Ravit Oren, Moran Hod-Marco, Maya Haus‐Cohen et al. · The Journal of Immunology · 2014 · 123 citations

Life Sciences, Immunology, Oncology +17

Shaping Functional Avidity of CAR T Cells: Affinity, Avidity, and Antigen Density That Regulate Response

Raanan Greenman, Yoav Pizem, Maya Haus‐Cohen et al. · Molecular Cancer Therapeutics · 2021 · 63 citations

Life Sciences, Immunology, Oncology +17

Disruption of P‐glycoprotein anticancer drug efflux activity by a small recombinant single‐chain Fv antibody fragment targeted to an extracellular epitope

Maya Haus‐Cohen, Yehuda G. Assaraf, Liat Binyamin et al. · International Journal of Cancer · 2004 · 15 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Phenotypic Models of CAR T-Cell Activation Elucidate the Pivotal Regulatory Role of CAR Downmodulation

Raanan Greenman, Yoav Pizem, Maya Haus‐Cohen et al. · Molecular Cancer Therapeutics · 2021 · 15 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibody

Liat Binyamin, Yehuda G. Assaraf, Maya Haus‐Cohen et al. · International Journal of Cancer · 2004 · 12 citations · Full text

Medicine, Oncology, Pharmacology +16